Semaglutide Use Linked to Lower Opioid Overdose Risk in Type 2 Diabetes
Semaglutide use was associated with a lower risk for opioid overdose than other antidiabetic medications in comorbid type 2 diabetes and OUD.
Related Articles
Radioiodine Therapy Unnecessary After Thyroidectomy in Low-Risk Thyroid Cancer
Radioiodine therapy was non-inferior to no radioiodine therapy after thyroidectomy among patients with low-risk differentiated thyroid cancer.
Causes, prevention, and management of diabetes-related foot ulcers
In this Review, we aim to complement the 2023 update of the guidelines of the International Working Group on the Diabetic Foot. We highlight the…
On-Demand Education – The Obesity Society
On-Demand Education: Science from The Obesity Society The Obesity Society (TOS) on-demand education is a great way to gain an in-depth understanding of essential aspects…
Society Provides Many Resources to Boost Members’ Careers – Endocrine News
A key mission of the Society is to foster the next generation of endocrine clinicians, researchers, and educators. To this end, the organization offers many…
Osteopenia: a key target for fracture prevention
Osteopenia was originally a qualitative term denoting bone that appeared to be less dense on radiographs. Since 1994, it has also had the quantitative meaning…
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.
The promise and hope of GLP-1 receptor agonists
GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits…
Technology for type 1 diabetes: what impact will it have?
Technological advances have profoundly affected people living with type 1 diabetes, their families or carers, and health-care systems. The innovations include the development of analogue…
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2–20 years) with type 1 diabetes: a population-based study
Hybrid closed-loop insulin delivery has no significant effect on the rate of severe hypoglycaemia, and is associated with an increased risk of diabetic ketoacidosis, but…